Author:
Alam Md. Adnanul,Uddin Muhammad Jamal,Khan Abed H,Arafat Shohael M
Publisher
Jaypee Brothers Medical Publishing
Reference12 articles.
1. 1. World Health Organization (WHO). Global tuberculosis report 2019. Geneva, Switzerland: World Health Organization; 2019. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports. ISBN: 9789241565714
2. 2. Quantrill SJ, Woodhead MA, Bell CE, et al. Side-effects of antituberculosis drug treatment in patients with chronic renal failure. Eur Respir J 2002;20(2):440–443. DOI: 10.1183/09031936.02.00298002.
3. 3. Siskind MS, Thienemann D, Kirlin L. Isoniazid-induced neurotoxicity in chronic dialysis patients: report of three cases and a review of the literature. Nephron 1993;64(2):303–306. DOI: 10.1159/000187331.
4. 4. Hussein MM, Mooij JM, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial 2003;16(1):38–44. DOI: 10.1046/j.1525-139x.2003.03010.x.
5. 5. Abbas MT, Khan FY, Sulimon S, et al. Encephalopathy secondary to isoniazid in patients on hemodialysis. Indian J Nephrol 2013;23(1):54–56. DOI: 10.4103/0971-4065.107206.